Medicinal Products

Kventiax SR 300 mg tablete s produljenim oslobađanjem

Name Kventiax SR 300 mg tablete s produljenim oslobađanjem
Marketing Authorisation Number HR-H-173044630
Active Substance quetiapinum
Pharmaceutical Form tableta s produljenim oslobađanjem
Strength 300 mg
Packaging [MA Number for Packaging] 10 tableta u blisteru, u kutiji  [HR-H-173044630-01]
30 tableta u blisteru, u kutiji  [HR-H-173044630-02]
50 tableta u blisteru, u kutiji  [HR-H-173044630-03]
60 tableta u blisteru, u kutiji  [HR-H-173044630-04]
90 tableta u blisteru, u kutiji  [HR-H-173044630-05]
100 tableta u blisteru, u kutiji  [HR-H-173044630-06]
Manufacturer Krka d.d., Novo Mesto, Slovenija
Marketing Authorisation Holder Krka - farma d.o.o., Radnička cesta 48, Zagreb
Marketing Authorisation Date 06.05.2015
MA Period of Validity 06.05.2020
Classification Number UP/I-530-09/14-01/39
Registration Number 381-12-01/30-15-13
Composition svaka tableta s produljenim oslobađanjem sadrži 300 mg kvetiapina u obliku kvetiapinfumarata
Prescription na recept
Type of prescription ponovljivi recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code N05AH04
Medicinal product marketed in the Croatia Da
SmPC download
PL download
Educational materials
for healthcare professionals
Podsjetnik o važnosti nadziranja metaboličkih parametara tijekom liječenja kvetiapinom, verzija 2
Back